Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation - Li, Lin; Li, Wen-Jun; Zheng, Xiang-Ru; Liu, Qing-Long; Du, Qian; Lai, Yu-Jie; Liu, Song-Qing (Molecular medicine (Cambridge, Mass.), 2022)
Keywords: Alzheimer Disease - drug therapy; Alzheimer Disease - etiology; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Alzheimer's disease; Amyloid beta-Peptides - metabolism; Amyloid beta-Protein Precursor - genetics; Animal cognition; Animals; Antibodies; Apoptosis; Biomarkers; Biomedical and Life Sciences; Biomedicine; Cognition - drug effects; Disease Models, Animal; Disease Susceptibility; Eriodictyol; Female; Ferroptosis; Ferroptosis - drug effects; Flavanones - chemistry; Flavanones - pharmacology; Flavonoids; Immunohistochemistry; Mice; Mice, Transgenic; Molecular Medicine; NF-E2-Related Factor 2 - metabolism; Nrf2; Peptides; Phosphorylation; Protein Aggregation, Pathological; Reactive Oxygen Species - metabolism; Receptors, Calcitriol - metabolism; Research Article; Signal Transduction; tau Proteins - metabolism; Transgenic animals; VDR; Vitamin D; United States--US; China; Ferroptosis; Alzheimer’s disease; VDR; Nrf2; Eriodictyol